Purpose of the study: The aim of this study was to analyze whether the risk of intracranial hemorrhage, focal neurological deficits and seizure from a cerebral Cavernous Malformations (CCM) changes significantly during pregnancy, delivery and post-partum, and based on the data from this study a recommendation or to give advice for clinical practice regarding maternal and fetal outcomes from the risk of haemorrhagic CCM during pregnancy. Yet there is a paucity of information relating to this in the medical literature. Basic procedures: We searched for publications on cavernous malformation in pregnancy in the MEDLINE database through PubMed. All publications till January 2019 were included in the search, and 16 related articles and 32 case reports were found. Main findings the studies reported that most patients (40%) presented with clinical symptoms of focal neurological deficits such as changes in the motor or sensory function, visual field deficits, ataxia, and hemiparesis. In most patients, the onset of symptoms was during the antepartum period, whereas some patients showed delayed symptoms at 2 weeks to 10 years postpartum. During pregnancy and the peripartum period, conservative management (no surgical intervention) may be used in cases with asymptomatic or minimally symptomatic lesions; however, in cases of severe symptoms occurring early in the course of pregnancy and endangering maternal and fetal life, neurosurgical intervention may be warranted before delivery. Principal conclusion: Most studies have suggested that pregnant women with CCMs can be managed safely even when symptomatic without a significant risk of adverse perinatal outcomes.